GURUFOCUS.COM » STOCK LIST » Financial Services » Capital Markets » Moelis & Co (NYSE:MC) » Definitions » ROE %

MC (Moelis) ROE % : 18.64% (As of Sep. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Moelis ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Moelis's annualized net income for the quarter that ended in Sep. 2024 was $67.6 Mil. Moelis's average Total Stockholders Equity over the quarter that ended in Sep. 2024 was $362.5 Mil. Therefore, Moelis's annualized ROE % for the quarter that ended in Sep. 2024 was 18.64%.

The historical rank and industry rank for Moelis's ROE % or its related term are showing as below:

MC' s ROE % Range Over the Past 10 Years
Min: -6.2   Med: 24.16   Max: 75.38
Current: 11.32

During the past 13 years, Moelis's highest ROE % was 75.38%. The lowest was -6.20%. And the median was 24.16%.

MC's ROE % is ranked better than
67.8% of 767 companies
in the Capital Markets industry
Industry Median: 5.68 vs MC: 11.32

Moelis ROE % Historical Data

The historical data trend for Moelis's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Moelis ROE % Chart

Moelis Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 24.81 38.76 75.38 32.21 -6.20

Moelis Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -11.34 -6.30 18.49 14.58 18.64

Competitive Comparison of Moelis's ROE %

For the Capital Markets subindustry, Moelis's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Moelis's ROE % Distribution in the Capital Markets Industry

For the Capital Markets industry and Financial Services sector, Moelis's ROE % distribution charts can be found below:

* The bar in red indicates where Moelis's ROE % falls into.



Moelis ROE % Calculation

Moelis's annualized ROE % for the fiscal year that ended in Dec. 2023 is calculated as

ROE %=Net Income (A: Dec. 2023 )/( (Total Stockholders Equity (A: Dec. 2022 )+Total Stockholders Equity (A: Dec. 2023 ))/ count )
=-24.7/( (444.495+352.141)/ 2 )
=-24.7/398.318
=-6.20 %

Moelis's annualized ROE % for the quarter that ended in Sep. 2024 is calculated as

ROE %=Net Income (Q: Sep. 2024 )/( (Total Stockholders Equity (Q: Jun. 2024 )+Total Stockholders Equity (Q: Sep. 2024 ))/ count )
=67.576/( (357.544+367.535)/ 2 )
=67.576/362.5395
=18.64 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Sep. 2024) net income data. ROE % is displayed in the 30-year financial page.


Moelis  (NYSE:MC) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Sep. 2024 )
=Net Income/Total Stockholders Equity
=67.576/362.5395
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(67.576 / 1095.02)*(1095.02 / 1101.9455)*(1101.9455 / 362.5395)
=Net Margin %*Asset Turnover*Equity Multiplier
=6.17 %*0.9937*3.0395
=ROA %*Equity Multiplier
=6.13 %*3.0395
=18.64 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Sep. 2024 )
=Net Income/Total Stockholders Equity
=67.576/362.5395
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (67.576 / 106.636) * (106.636 / 62.256) * (62.256 / 1095.02) * (1095.02 / 1101.9455) * (1101.9455 / 362.5395)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.6337 * 1.7129 * 5.69 % * 0.9937 * 3.0395
=18.64 %

Note: The net income data used here is four times the quarterly (Sep. 2024) net income data. The Revenue data used here is four times the quarterly (Sep. 2024) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Moelis ROE % Related Terms

Thank you for viewing the detailed overview of Moelis's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Moelis Business Description

Traded in Other Exchanges
Address
399 Park Avenue, 4th Floor, New York, NY, USA, 10022
Moelis & Co is an independent investment bank that provides strategic and financial advice to a diverse client base, including corporations, financial sponsors, governments, and sovereign wealth funds. The company assists its clients in achieving their strategic goals by offering comprehensive, globally integrated financial advisory services across all industry sectors. It also advises clients on their critical decisions, including mergers and acquisitions, recapitalizations and restructurings, capital markets transactions, and other corporate finance matters. it generates revenue from advisory transactions. The firm derives a majority of its revenue from the United States followed by Europe and the rest of the World.
Executives
Christopher Callesano officer: SVP & Principal Acct Officer C/O MOELIS & COMPANY, 399 PARK AVENUE, 5TH FLOOR, NEW YORK NY 10022
Kenneth Moelis director, 10 percent owner, officer: Chairman and CEO C/O MOELIS & COMPANY, 399 PARK AVENUE, 5TH FLOOR, NEW YORK NY 10022
Kenneth Shropshire director C/O MOELIS & COMPANY, 399 PARK AVENUE, 5TH FLOOR, NEW YORK NY 10011
Ciafone Katherine Pilcher officer: Chief Operating Officer 399 PARK AVE, NEW YORK NY 10022
Joseph Simon officer: Chief Financial Officer C/O MOELIS & COMPANY, 399 PARK AVENUE, 5TH FLOOR, NEW YORK NY 10022
Navid Mahmoodzadegan director, officer: Managing Director C/O MOELIS & COMPANY, 399 PARK AVENUE, 5TH FLOOR, NEW YORK NY 10022
Jeffrey Raich director, officer: Managing Director C/O MOELIS & COMPANY, 399 PARK AVENUE, 5TH FLOOR, NEW YORK NY 10022
Osamu R. Watanabe officer: General Counsel and Secretary C/O MOELIS & COMPANY, 399 PARK AVENUE, 5TH FLOOR, NEW YORK NY 10022
Eric Cantor director C/O MOELIS & COMPANY, 399 PARK AVENUE, 5TH FLOOR, NEW YORK NY 10022
Elizabeth Crain officer: Chief Operating Officer C/O MOELIS & COMPANY, 399 PARK AVENUE, 5TH FLOOR, NEW YORK NY 10022
Laila Worrell director 399 PARK AVENUE, NEW YORK NY 10022
Yolonda C Richardson director 399 PARK AVENUE, NEW YORK NY 10022
Leaman J Richard Iii director, officer: Managing Partner C/O MOELIS & COMPANY, 399 PARK AVENUE, 5TH FLOOR, NEW YORK NY 10022
John A Allison director PO BOX 1250, WINSTON SALEM NC 27102-1250
Yvonne Greenstreet director PACIRA PHARMACEUTICALS, INC., 5 SYLVAN WAY, PARSIPPANY NJ 07054